Login

The CEO of Freenet AG discusses the company's strategic ambitions in an interview 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Innovative Protein Folding Predictions|Eugene Williams,Chairman,Promis Neurosciences Inc
00:10:00
HighGold Mining Focuses on High-Grade Gold Assets in North America
00:10:00
Maximizing Health Savings Accounts for Effective Tax Planning
00:10:00
B3 Procurement - This is what it's like to work as a consultant | Anette Billing, CEO, B3 Consulting Group AB (publ) B3:STO
00:10:00
Gold Project in Ethiopia Poised for Development with Government Support
00:10:00
Miki leads Doosan Corporation's strategy and serves as CEO of Doosan Tesna, focusing on enhancing their semiconductor business and advancing technological innovations​ |Jong-Do Lee is Chairman & Chief Executive Officer at TESNA Inc
00:10:00
Richardson Electronics, Ltd. (NASDAQ: RELL) CEO Edward Richardson sat down with Proactive Investors at the 11th Annual LD Micro Main Event.
00:10:00
A smart inside take on the day’s politics|Jonathan Capehart,Associate Editor, The Washington Post
00:10:00
The pandemic accelerated our focus on operational resilience and digital transformation.
00:10:00
The CEO of Learning Technologies Group plc discusses the company's impressive growth and transition from SPAC to public listing.
00:10:00
Leading LGBTQIA+/Allies investment syndicate that has invested $110M|Paul Grossinger,Founder,Gaingels
00:10:00
Zero to infinity is possible when you are ready to lose all of it|Charles Hudson,General Partner, Precursor Ventures

© 2017 - Neuhu+